New RNA Platform Boosts Yeast Metabolic Production
The hfCas13d system enables multiplexed gene repression to increase hydroxydecanoic acid yields in fermentation.
Updated on Oct. 15, 2026 in Life Sciences
Researchers have developed an hfCas13d and circular guide RNA platform that significantly improves gene knockdown efficiency in yeast and E. coli. This research-stage system enables multiplexed pathway repression, allowing for more precise metabolic engineering.
Why it matters
The ability to precisely arrest intermediate metabolic reactions in yeast enables the efficient biological production of high-value compounds like hydroxydecanoic acid. This platform provides a modular approach to metabolic pathway control, potentially accelerating the development of industrial-scale fermentation processes.
The platform utilizes a circular guide RNA precursor architecture to achieve gene knockdown, achieving a hydroxydecanoic acid titer of 37.2 g/L in bioreactors compared to 17.8 g/L in shake flask testing. It supports multiplexed pathway repression using dual circular guide RNA arrays, which also reduces the formation of metabolic byproducts.
The players
Candida viswanathii
An oleaginous yeast species utilized as the primary biological host for metabolic engineering and hydroxydecanoic acid production.
E. coli
A widely used model organism employed here to test the cross-species applicability of the RNA knockdown platform.
The details
The system employs hfCas13d, a high-fidelity enzyme capable of targeting and degrading specific RNA sequences, paired with a circular guide RNA precursor architecture. By organizing these guides into arrays, researchers can simultaneously repress multiple genes within a metabolic pathway. This prevents yeast cells from diverting resources into unwanted secondary reactions, thereby forcing the carbon flow toward the production of hydroxydecanoic acid.
Timeline
October 15, 2026: Publication date of the research findings.
The Tech Race
This development moves beyond standard CRISPR-Cas9 genome editing, which permanently alters DNA, by using the transient, tunable RNA-targeting capabilities of the hfCas13d system. It marks a shift toward highly multiplexed metabolic control in industrial microorganisms, mirroring efforts to optimize synthetic biology platforms for large-scale bio-manufacturing.
This platform remains in the research stage and does not yet impact commercial manufacturing workflows. Biologists and industrial engineers can monitor the adoption of circular guide RNA architectures as a potential method to increase yields in specialty chemical and biofuel fermentation.
The takeaway
This platform demonstrates that precise, multiplexed gene repression can significantly improve output titers for specific metabolic products. Future research should watch for benchmarks comparing these circular guide arrays against standard CRISPR interference (CRISPRi) methods in long-term, industrial bioreactor runs.
Further reading
For broader trends in synthetic biology and cellular engineering, visit Life Sciences.
Source note: This article includes information reported by Nature.
